2005
DOI: 10.1097/01.tp.0000157119.39395.c3
|View full text |Cite
|
Sign up to set email alerts
|

Reepithelialized Orthotopic Tracheal Allografts Expand Memory Cytotoxic T Lymphocytes But Show No Evidence of Chronic Rejection

Abstract: These observations suggest that long-term withdrawal of immunosuppression does not lead to chronic tracheal rejection even in the presence of alloantigen specific cytotoxic T-lymphocyte responses and that the reepithelialized grafts may contain donor elements that impact the generation of immunity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
7
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 28 publications
2
7
0
1
Order By: Relevance
“…To reduce allograft antigenicity further, the inner surface of the trachea should be remodeled and replaced by the recipient's epithelium [20]. This can prevent chronic rejection even after withdrawal of immunosuppression [41]. If the denuded lining of the tracheal allograft is not promptly covered by the recipient's epithelium, fibroproliferative tissues will enter the tracheal lumen via the membranous part [18] and cause airway obliteration and also cause the rejection process to continue unchecked.…”
Section: Discussionmentioning
confidence: 99%
“…To reduce allograft antigenicity further, the inner surface of the trachea should be remodeled and replaced by the recipient's epithelium [20]. This can prevent chronic rejection even after withdrawal of immunosuppression [41]. If the denuded lining of the tracheal allograft is not promptly covered by the recipient's epithelium, fibroproliferative tissues will enter the tracheal lumen via the membranous part [18] and cause airway obliteration and also cause the rejection process to continue unchecked.…”
Section: Discussionmentioning
confidence: 99%
“…The murine model of orthotopic tracheal transplantation that was adopted in this study has proved to be a good model for experimental study of the reepithelialization of the tracheal graft. [3][4][5][6] With murine orthotopic and heterotopic tracheal transplantation models, it has been proved that immunosuppressors can be withdrawn without inciting acute and chronic rejection if the donor epithelium is progressively replaced by recipient-derived epithelium. 4,5 It takes at least a 48-day period to complete reepithelialization in immunosuppressed orthotopic tracheal allografts, 6 however, so it is necessary to find a way to accelerate the epithelial regeneration of the tracheal graft.…”
Section: Discussionmentioning
confidence: 99%
“…Because the epithelium of donor has been thought to be the primary target of allograft rejection, 2 reepithelialization of orthotopic tracheal grafts with recipientderived epithelium may be a great help in preventing airway obliteration and rejection. [3][4][5] Tracheal reepithelialization takes a long time, 6 however, so finding a way to accelerate the epithelium regeneration may contribute to the success of tracheal transplant.…”
mentioning
confidence: 99%
“…[10][11][12][13] Given the immunoprivileged nature of chondrocytes, complete decellularization of donor trachea may not be necessary for a suitable tracheal replacement. [14][15][16][17] Contemporary approaches have begun to assess the feasibility of partial decellularization approaches, removing immunogenic cell types and preserving immunoprivileged chondrocytes. 18,19 We have developed a mouse model of orthotopic tracheal replacement which permits the assessment of the tracheal replacements in vivo.…”
Section: Introductionmentioning
confidence: 99%